Multi-disciplinary Strategies for Orbital and Organ Preservation in Sinonasal Cancer
6th March, 2026, 14:25 - 15:25
Pacific D
This session will examine the current state of art in organ preservation in sinonasal cancers, including the use of chemotherapy, immunotherapy and radiosurgery to avoid morbid surgery.
Objectives
At the conclusion of this session, attendees will be able to:
- Assess indications for orbital exenteration versus preservation.
- Discuss indications for induction chemotherapy and assess criteria for selecting post-induction chemotherapy treatments.
- Discuss benefits/drawbacks of post-chemotherapy treatment strategies including surgery versus radiotherapy.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
Speaker | Title | Role | Times |
---|---|---|---|
James Byrd 706-721-6100 |
Moderator | - | |
Robbie Woods +353877832052 |
Moderator | - | |
Ian Witterick 416-586-4800x8313 |
Surgical Management of Orbital Invasion – When is It Safe to Preserve the Orbit? | Speaker | 2:25 pm - 2:33 pm |
Neal Akhave 832-292-5971 |
Induction Chemotherapy and Immunotherapy in Sinonasal Malignancies – What is the Evidence? | Speaker | 2:33 pm - 2:41 pm |
Mario Turri-Zanoni +393286757585 |
When to Do Radiotherapy vs Surgery for Organ Preservation Following Induction Chemotherapy – The European Perspective | Speaker | 2:41 pm - 2:49 pm |
Shirley Su 713-792-4726 |
Immunotherapy and Radiotherapy for Organ Preservation in Sinonasal Mucosal Melanoma – Preliminary Results of the PRISM Study | Speaker | 2:49 pm - 2:57 pm |
Robbie Woods +353877832052 |
Case Presentations & Discussion | Speaker | 2:57 pm - 3:25 pm |
James Byrd 706-721-6100 |
Case Presentations & Discussion | Speaker | 2:57 pm - 3:25 pm |